| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $329.2M | +7.8% |
| Cost of Revenue | $38.6M | +12.0% |
| Gross Profit | $290.6M | +7.2% |
| R&D Expense | $276.7M | +1.7% |
| SG&A Expense | $213.0M | +10.6% |
| Operating Income | -$212.1M | -2.8% |
| Interest Expense | $37.1M | +14.3% |
| Pre-tax Income | -$242.0M | -0.2% |
| Income Tax | -$5.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $148.8M | -39.3% |
| Short-term Investments | $144.8M | -39.0% |
| Accounts Receivable | $66.2M | +25.7% |
| Inventory | $23.8M | -11.2% |
| Current Assets | $423.8M | -29.0% |
| Total Assets | $724.2M | -20.0% |
| Current Liabilities | $139.0M | -4.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$166.6M | +17.7% |
| Capital Expenditures | $3.8M | -3.0% |
| Investing Cash Flow | $92.3M | +17.2% |
| Financing Cash Flow | -$7.5M | -103.5% |
| Free Cash Flow | -$170.3M | +17.5% |
| -161.4% |
| Net Income | -$236.6M | +5.5% |
| EPS (Basic) | -$0.82 | +10.9% |
| EPS (Diluted) | -$0.82 | +10.9% |
| Long-term Debt |
| $392.0M |
| +0.7% |
| Total Liabilities | $601.1M | +0.6% |
| Stockholders' Equity | $123.0M | -60.0% |